Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 41.70M | $ 132.50M | $ 24.80M | $ 25.80M | $ 206.80M |
Total Assets | $ 1.38B | $ 1.14B | $ 983.40M | $ 916.30M | $ 694.60M |
Total Debt | $ 439.70M | $ 402.30M | $ 254.50M | $ 261.80M | $ 33.70M |
Net Debt | $ 398.00M | $ 269.80M | $ 229.70M | $ 236.00M | $ -173.10M |
Total Liabilities | $ 710.80M | $ 590.90M | $ 442.40M | $ 416.00M | $ 163.90M |
Stockholders Equity | $ 662.00M | $ 547.70M | $ 536.30M | $ 496.20M | $ 527.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |